Advancing Reliable Data for Cancer Control in the Central America Four Region
The Central America Four (CA-4) region, comprising Guatemala, Honduras, El Salvador, and Nicaragua, is the largest low- and middle-income country region in the Western Hemisphere, with over 36 million inhabitants. The CA-4 nations share a common geography, history, language, and development indices,...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2018-12-01
|
Series: | Journal of Global Oncology |
Online Access: | https://ascopubs.org/doi/10.1200/JGO.2016.008227 |
_version_ | 1819047511649681408 |
---|---|
author | Marion Piñeros Silvina Frech Lindsay Frazier Mathieu Laversanne Joaquin Barnoya Claudia Garrido Eduardo Gharzouzi Andrea Chacón Soad Fuentes Alabi Lisseth Ruiz de Campos Jacqueline Figueroa Ricardo Dominguez Ofelia Rojas Rosario Pereira Carla Rivera Douglas R. Morgan |
author_facet | Marion Piñeros Silvina Frech Lindsay Frazier Mathieu Laversanne Joaquin Barnoya Claudia Garrido Eduardo Gharzouzi Andrea Chacón Soad Fuentes Alabi Lisseth Ruiz de Campos Jacqueline Figueroa Ricardo Dominguez Ofelia Rojas Rosario Pereira Carla Rivera Douglas R. Morgan |
author_sort | Marion Piñeros |
collection | DOAJ |
description | The Central America Four (CA-4) region, comprising Guatemala, Honduras, El Salvador, and Nicaragua, is the largest low- and middle-income country region in the Western Hemisphere, with over 36 million inhabitants. The CA-4 nations share a common geography, history, language, and development indices, and unified with open borders in 2006. The growing CA-4 cancer burden among the noncommunicable diseases is expected to increase 73% by 2030, which argues for a regional approach to cancer control. This has driven efforts to establish population-based cancer registries as a central component of the cancer control plans. The involvement of international and academic partners in an array of initiatives to improve cancer information and control in the CA-4 has accelerated over the past several years. Existing data underscore that the infectious cancers (cervical, stomach, and liver) are a particular burden. All four countries have committed to establishing regional population-based cancer registries and have advanced significantly in pediatric cancer registration. The challenges common to each nation include the lack of national cancer control plans and departments, competing health priorities, lack of trained personnel, and sustainability strategies. General recommendations to address these challenges are outlined. The ongoing regional, international, and academic cooperation has proven helpful and is expected to continue to be a powerful instrument to contribute to the design and implementation of long-term national cancer control plans. |
first_indexed | 2024-12-21T11:01:32Z |
format | Article |
id | doaj.art-df48951e946645ac9b00d81220dc327d |
institution | Directory Open Access Journal |
issn | 2378-9506 |
language | English |
last_indexed | 2024-12-21T11:01:32Z |
publishDate | 2018-12-01 |
publisher | American Society of Clinical Oncology |
record_format | Article |
series | Journal of Global Oncology |
spelling | doaj.art-df48951e946645ac9b00d81220dc327d2022-12-21T19:06:20ZengAmerican Society of Clinical OncologyJournal of Global Oncology2378-95062018-12-01411110.1200/JGO.2016.0082271Advancing Reliable Data for Cancer Control in the Central America Four RegionMarion Piñeros0Silvina Frech1Lindsay Frazier2Mathieu Laversanne3Joaquin Barnoya4Claudia Garrido5Eduardo Gharzouzi6Andrea Chacón7Soad Fuentes Alabi8Lisseth Ruiz de Campos9Jacqueline Figueroa10Ricardo Dominguez11Ofelia Rojas12Rosario Pereira13Carla Rivera14Douglas R. Morgan15Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.Marion Piñeros and Mathieu Laversanne, International Agency for Research on Cancer, Lyon, France; Silvina Frech, US National Cancer Institute, Bethesda, MD; Lindsay Frazier, Dana-Farber/Children’s Cancer Center, Boston MA; Joaquin Barnoya and Eduardo Gharzouzi, Instituto de Cancerologia; Claudia Garrido, Unidad Nacional Oncología Pediátrica, Guatemala City, Guatemala; Joaquin Barnoya, Washington University in St. Louis, St. Louis, MO; Andrea Chacón, Unidad Nacional para la Prevención y control del Cáncer, Ministerio de Salud; Soad Fuentes Alabi, Hospital Benjamín Bloom, Ministerio de Salud; Lisseth Ruiz de Campos, Asociación Salvadoreña para la Prevención del Cáncer, San Salvador, El Salvador; Jacqueline Figueroa, Unidad de Registro de Cáncer, Secretaria de Salud, Tegucigalpa; Ricardo Dominguez, Hospital de Occidente, Secretaria de Salud, Copán, Honduras; Ofelia Rojas, Rosario Pereira, and Carla Rivera, Universidad Nacional Autónoma de Nicaragua, León, Nicaragua; and Douglas R. Morgan, Vanderbilt University, Nashville, TN.The Central America Four (CA-4) region, comprising Guatemala, Honduras, El Salvador, and Nicaragua, is the largest low- and middle-income country region in the Western Hemisphere, with over 36 million inhabitants. The CA-4 nations share a common geography, history, language, and development indices, and unified with open borders in 2006. The growing CA-4 cancer burden among the noncommunicable diseases is expected to increase 73% by 2030, which argues for a regional approach to cancer control. This has driven efforts to establish population-based cancer registries as a central component of the cancer control plans. The involvement of international and academic partners in an array of initiatives to improve cancer information and control in the CA-4 has accelerated over the past several years. Existing data underscore that the infectious cancers (cervical, stomach, and liver) are a particular burden. All four countries have committed to establishing regional population-based cancer registries and have advanced significantly in pediatric cancer registration. The challenges common to each nation include the lack of national cancer control plans and departments, competing health priorities, lack of trained personnel, and sustainability strategies. General recommendations to address these challenges are outlined. The ongoing regional, international, and academic cooperation has proven helpful and is expected to continue to be a powerful instrument to contribute to the design and implementation of long-term national cancer control plans.https://ascopubs.org/doi/10.1200/JGO.2016.008227 |
spellingShingle | Marion Piñeros Silvina Frech Lindsay Frazier Mathieu Laversanne Joaquin Barnoya Claudia Garrido Eduardo Gharzouzi Andrea Chacón Soad Fuentes Alabi Lisseth Ruiz de Campos Jacqueline Figueroa Ricardo Dominguez Ofelia Rojas Rosario Pereira Carla Rivera Douglas R. Morgan Advancing Reliable Data for Cancer Control in the Central America Four Region Journal of Global Oncology |
title | Advancing Reliable Data for Cancer Control in the Central America Four Region |
title_full | Advancing Reliable Data for Cancer Control in the Central America Four Region |
title_fullStr | Advancing Reliable Data for Cancer Control in the Central America Four Region |
title_full_unstemmed | Advancing Reliable Data for Cancer Control in the Central America Four Region |
title_short | Advancing Reliable Data for Cancer Control in the Central America Four Region |
title_sort | advancing reliable data for cancer control in the central america four region |
url | https://ascopubs.org/doi/10.1200/JGO.2016.008227 |
work_keys_str_mv | AT marionpineros advancingreliabledataforcancercontrolinthecentralamericafourregion AT silvinafrech advancingreliabledataforcancercontrolinthecentralamericafourregion AT lindsayfrazier advancingreliabledataforcancercontrolinthecentralamericafourregion AT mathieulaversanne advancingreliabledataforcancercontrolinthecentralamericafourregion AT joaquinbarnoya advancingreliabledataforcancercontrolinthecentralamericafourregion AT claudiagarrido advancingreliabledataforcancercontrolinthecentralamericafourregion AT eduardogharzouzi advancingreliabledataforcancercontrolinthecentralamericafourregion AT andreachacon advancingreliabledataforcancercontrolinthecentralamericafourregion AT soadfuentesalabi advancingreliabledataforcancercontrolinthecentralamericafourregion AT lissethruizdecampos advancingreliabledataforcancercontrolinthecentralamericafourregion AT jacquelinefigueroa advancingreliabledataforcancercontrolinthecentralamericafourregion AT ricardodominguez advancingreliabledataforcancercontrolinthecentralamericafourregion AT ofeliarojas advancingreliabledataforcancercontrolinthecentralamericafourregion AT rosariopereira advancingreliabledataforcancercontrolinthecentralamericafourregion AT carlarivera advancingreliabledataforcancercontrolinthecentralamericafourregion AT douglasrmorgan advancingreliabledataforcancercontrolinthecentralamericafourregion |